North Dakota last year passed a bipartisan law limiting patients’ out-of-pocket insulin costs under state-regulated health plans to $25 per month. The state is one of 29 that have enacted similar measures, but its cap does not apply to federally regulated employer health plans. Data show that annual out-of-pocket insulin costs for privately insured patients with diabetes fell from $470 in 2018 to $220 in 2025, while Congress is currently considering a nationwide cap on insulin prices.
Source:KFF Health News · Read Original
Leave a Reply